Medical Device Translation Services for MDR, IVDR and Global Markets

Medical device translation services cover the controlled translation of regulated medical device content, including IFUs, eIFUs, labelling, implant cards, packaging, safety warnings, FSNs, FSCAs, technical documentation, clinical evaluation, PMS and PMCF content, regulatory submissions, software UI, UDI and EUDAMED content, QMS documentation and training materials. The work is performed by qualified medical device linguists, with controlled terminology, translation memories and consistency across the device documentation set. Translated content is then reviewed and approved by the manufacturer according to internal regulatory, QARA, quality and product processes for the relevant device and target markets.

MDR translation services support medical device manufacturers in meeting language expectations under EU Regulation 2017/745, including MDR language requirements for IFUs, labelling, implant cards, packaging, FSNs and authority communications. EU MDR language requirements and EU medical device labeling language requirements are partly defined at national level and can vary by Member State and intended user group. AbroadLink supports translation, terminology and traceability across the languages requested by the manufacturer. Final interpretation of MDR translation requirements, country lists and language strategy remains with the regulatory affairs team and competent authorities.

An ISO 13485 translation company implements a quality management system aligned with the medical device industry, including stricter linguist selection, controlled processes and documentation suited to regulated content. AbroadLink combines ISO 13485 with ISO 17100 for translation services and ISO 9001, supporting medical device translation services across MDR, IVDR and other contexts. ISO 13485 does not replace the manufacturer's own QMS or substitute for notified body and authority assessments. It supports controlled translation workflows that fit into the manufacturer's documentation, audit readiness and supplier qualification strategy.

MDR translation deals with regulated medical device content that has to remain consistent with technical files, labelling, IFUs, implant cards, vigilance and clinical evidence over time. Unlike general medical translation, it is tied to MDR and IVDR terminology, harmonised standards and country-specific language requirements for medical devices. Qualified medical device linguists work with controlled terminology, translation memories and references across product families. Workflows are matched to device class, document risk and audience. Certificates can be made available through CertLink to support QMS evidence and audit readiness with notified bodies and authorities.

No. The accuracy requirement does not change for shorter updates, administrative documents, distributor support content, repeated content or internal drafts. Translated medical device content must always accurately and completely reflect the approved source. A lower-risk workflow may be appropriate when the content type, intended audience, device context, regulatory context, target markets and client-side controls support that choice. Different workflows manage the probability and consequences of translation error, not the accuracy objective itself. For IFUs, labelling, safety information and authority-facing content, stronger workflows are usually more appropriate.

AI can support medical device translation only as a controlled pre-translation step, not as a replacement for qualified human review. Through aiHubLink, AbroadLink can use client terminology and previous translations to generate an initial draft, which is then fully reviewed and validated by qualified medical device linguists within ISO-based workflows. For IFUs, labelling, implant cards, safety warnings, FSNs, FSCAs, technical documentation, clinical content, PMS and PMCF, regulatory submissions, software UI and patient-facing content, AI is positioned only as a controlled support option, with traceability through CertLink where appropriate.

No. Medical device translation services, MDR translation services, ISO 13485 translation company support and medical device localization do not guarantee MDR compliance, IVDR compliance, FDA compliance, notified body acceptance, competent authority acceptance, audit acceptance, CE marking, product approval, safe use, correct use, patient understanding, market access, regulatory clearance or business outcomes. These outcomes depend on the manufacturer's regulatory, QARA, PRRC, quality, clinical, safety, product, technical, software, usability, validation, legal and local market teams, plus the relevant notified body or authority. AbroadLink supports translation, review, terminology, workflow selection and traceability.

Useful inputs include approved source IFUs, labelling, implant cards, technical files, clinical content, PMS, PMCF, regulatory submissions, software strings and related medical device documentation, plus any previous translated versions, terminology lists or translation memories. Target languages and markets, device class, intended users, regulatory context and any internal QMS or QARA procedures are also helpful. Editable source files reduce cost and lead time. Information on content risk profile, MDR or IVDR scope and notified body context supports workflow selection and proposal of a risk-based medical device translation workflow that fits your documentation strategy.